Orazio Caffo

27PUBLICATIONS
172CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsChiropracticMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Feb 13, 2026
Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.

Antonello Veccia, Ettore D'Argento, Floriana Morgillo

|Jan 28, 2026
Long-Term Oncological Outcomes in Metastatic Prostate Cancer Patients Who Are Able to Maintain/Recover Ongoing Anticancer Therapy After SARS-CoV-2 Infection-Results of the MEET-URO 22 Study.

Orazio Caffo, Umberto Basso, Antonello Veccia

|Sep 10, 2025
Germline Findings From Tumor-Only Comprehensive Genomic Profiling in the RATIONAL Study: A Missed Opportunity?

Riziero Esposito Abate, Alessandro Morabito, Michele Milella

|May 14, 2025
Prostate Cancer Diagnosis and Treatment in Elderly Patients: A Cross-Sectional Survey Exploring Practice Patterns and Preferences of Uro-Oncologists in Northeast Italy.

Filippo Carletti, Giuseppe Reitano, Laura Evangelista

|Feb 26, 2025
Osimertinib in the Treatment of Epidermal Growth Factor Receptor-Mutant Early and Locally Advanced Stages of Non-Small-Cell Lung Cancer: Current Evidence and Future Perspectives.

Antonello Veccia, Mariachiara Dipasquale, Martina Lorenzi

Pageof 5

Frequent Collaborators

6 joint publications

Antonello Veccia

4 joint publications

Giuseppe Fornarini

4 joint publications

Ugo De Giorgi

4 joint publications

Umberto Basso